BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $31,000 | -52.3% | 11,309 | -6.6% | 0.00% | – |
| Q4 2021 | $65,000 | -38.1% | 12,103 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $105,000 | -32.7% | 12,466 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $156,000 | -39.1% | 12,762 | +21.1% | 0.00% | 0.0% |
| Q1 2021 | $256,000 | -24.0% | 10,539 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $337,000 | +3.1% | 10,510 | -2.8% | 0.00% | -50.0% |
| Q3 2020 | $327,000 | +3.2% | 10,812 | +43.8% | 0.00% | 0.0% |
| Q2 2020 | $317,000 | +78.1% | 7,517 | +5.2% | 0.00% | +100.0% |
| Q1 2020 | $178,000 | – | 7,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |